SCHEMBL30389973

SCHEMBL30389973

CC[C@H](C)[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ OPRD1 P41143 7/20 0.52
▸ OPRM1 P35372 2/20 0.49
▸ SLC6A2 P23975 1/20 0.48
▸ NTSR1 P30989 2/20 0.48
▸ LNPEP Q9UIQ6 3/20 0.48
▸ ANPEP P15144 1/20 0.48
▸ REN P00797 1/20 0.47
▸ BDKRB2 P30411 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30311937 0.84 CMA1 (0.51) OPRD1OPRM1SLC6A2REN
SCHEMBL29509558 0.83 MAPK8 (0.53) OPRD1NTSR1REN
SCHEMBL31461843 0.82 OPRD1 (0.54) OPRD1OPRM1NTSR1REN
SCHEMBL31151792 0.81 OPRD1 (0.55) OPRD1OPRM1SLC6A2
SCHEMBL32674541 0.81 CALCRL (0.53) OPRD1SLC6A2LNPEPANPEPREN
SCHEMBL38659426 0.81 AGTR2 (0.52) OPRD1OPRM1SLC6A2NTSR1REN
SCHEMBL31067243 0.81 OPRD1 (0.54) OPRD1OPRM1NTSR1
SCHEMBL31670643 0.81 OPRD1 (0.59) OPRD1OPRM1NTSR1REN
SCHEMBL29706215 0.81 F2 (0.45) OPRD1NTSR1LNPEPANPEPREN
SCHEMBL31461866 0.80 LNPEP (0.54) OPRD1OPRM1NTSR1LNPEPANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116041429-B Rana spinosa polypeptide for inhibiting xanthine oxidase activity as well as preparation method and application thereof 集美大学 2024-11-01 — — CN disclosed
CN-116041429-A Rana spinosa polypeptide for inhibiting xanthine oxidase activity as well as preparation method and application thereof 集美大学 2023-05-02 — — CN disclosed
Send feedback